Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.

Author: ChenLongtu, FengBin, IlhamSheikh J

Paper Details 
Original Abstract of the Article :
Visceral pain is a leading symptom for patients with irritable bowel syndrome (IBS) that affects 10% - 20 % of the world population. Conventional pharmacological treatments to manage IBS-related visceral pain is unsatisfactory. Recently, medications have emerged to treat IBS patients by targeting th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556397/

データ提供:米国国立医学図書館(NLM)

Managing Irritable Bowel Syndrome Pain: A Pharmacological Approach

This research explores the challenges of managing visceral pain in irritable bowel syndrome (IBS), a common condition that affects millions of people. The authors review the current pharmacological approaches to IBS pain management, emphasizing the need for more effective treatments that target the gastrointestinal tract and peripheral nerves while minimizing central nervous system (CNS) side effects.

A New Frontier in IBS Pain Management

The research highlights the need for more effective and targeted treatments for IBS pain, like finding a hidden oasis in the desert of pain management. The authors discuss the limitations of conventional treatments and the emergence of new medications that offer hope for better pain relief with fewer side effects.

Balancing Efficacy and Safety

The authors emphasize the importance of balancing efficacy and safety in IBS pain management. This is a crucial challenge, like navigating a treacherous desert, where finding the right path requires careful consideration and a balanced approach. The authors encourage further research to develop new medications that offer effective pain relief without compromising patient safety and well-being.

Dr. Camel's Conclusion

This research is a call to action, a signal in the desert to guide us toward better treatments for IBS pain. By exploring new targets and developing innovative medications, we can bring relief to millions of people struggling with this debilitating condition. The desert of IBS research holds countless possibilities, and with continued efforts, we can find a path toward better health and well-being for all.
Date :
  1. Date Completed n.d.
  2. Date Revised 2020-09-30
Further Info :

Pubmed ID

28824858

DOI: Digital Object Identifier

PMC5556397

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.